214 related articles for article (PubMed ID: 7523315)
1. Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2.
Yasumura S; Lin WC; Weidmann E; Hebda P; Whiteside TL
Int J Cancer; 1994 Oct; 59(2):225-34. PubMed ID: 7523315
[TBL] [Abstract][Full Text] [Related]
2. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
[TBL] [Abstract][Full Text] [Related]
4. How interleukin-2 can affect human fibroblasts behaviour.
Plaisance S; Alileche A; Han D; Rubinstein E; Sahraoui Y; Jasmin C; Azzarone B
Pathol Res Pract; 1994 Oct; 190(9-10):942-9. PubMed ID: 7899144
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 2 production and interleukin 2 receptor expression by human immature leukemic T cells.
Sahraoui Y; Allouche M; Ammar A; Spanakis E; Clemenceau C; Jasmin C; Perraki M; Varela-Millot C; Georgoulias V
Leukemia; 1992 Oct; 6(10):1025-35. PubMed ID: 1405755
[TBL] [Abstract][Full Text] [Related]
6. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
[TBL] [Abstract][Full Text] [Related]
7. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
8. In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.
Hathorn RW; Tso CL; Kaboo R; Pang S; Figlin R; Sawyers C; deKernion JB; Belldegrun A
Cancer; 1994 Oct; 74(7):1904-11. PubMed ID: 7521786
[TBL] [Abstract][Full Text] [Related]
9. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
[TBL] [Abstract][Full Text] [Related]
10. Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth.
Lin WC; Yasumura S; Suminami Y; Sung MW; Nagashima S; Stanson J; Whiteside TL
J Immunol; 1995 Nov; 155(10):4805-16. PubMed ID: 7594483
[TBL] [Abstract][Full Text] [Related]
11. Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.
Weidmann E; Sacchi M; Plaisance S; Heo DS; Yasumura S; Lin WC; Johnson JT; Herberman RB; Azzarone B; Whiteside TL
Cancer Res; 1992 Nov; 52(21):5963-70. PubMed ID: 1394222
[TBL] [Abstract][Full Text] [Related]
12. Transfer of interleukin 2 receptor genes into squamous cell carcinoma. Modification of tumor cell growth.
Lin WC; Yasumura S; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1229-35. PubMed ID: 8217083
[TBL] [Abstract][Full Text] [Related]
13. Induction of the intercellular adhesion molecule (ICAM-1) on squamous cell carcinoma by interferon gamma.
Scher RL; Koch WM; Richtsmeier WJ
Arch Otolaryngol Head Neck Surg; 1993 Apr; 119(4):432-8. PubMed ID: 8096142
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas.
Hoon DS; Okun E; Banez M; Irie RF; Morton DL
Cancer Res; 1991 Oct; 51(20):5687-93. PubMed ID: 1913686
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.
Malabarba MG; Rui H; Deutsch HH; Chung J; Kalthoff FS; Farrar WL; Kirken RA
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):865-72. PubMed ID: 8920992
[TBL] [Abstract][Full Text] [Related]
16. Human melanoma cells express a functional interleukin-2 receptor.
Plaisance S; Rubinstein E; Alileche A; Han DS; Sahraoui Y; Mingari MC; Bellomo R; Rimoldi D; Colombo MP; Jasmin C
Int J Cancer; 1993 Aug; 55(1):164-70. PubMed ID: 8344747
[TBL] [Abstract][Full Text] [Related]
17. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A inhibits the interleukin 2 receptor alpha chain gene transcription but not its cell surface expression: the alpha chain stability can explain this discrepancy.
Hémar A; Dautry-Varsat A
Eur J Immunol; 1990 Dec; 20(12):2629-35. PubMed ID: 2269327
[TBL] [Abstract][Full Text] [Related]
19. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
Myers JN; Yasumura S; Suminami Y; Hirabayashi H; Lin Wc; Johnson JT; Lotze MT; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):127-35. PubMed ID: 9816099
[TBL] [Abstract][Full Text] [Related]
20. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL
J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
